Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED.

Pierre Fabre, EspeRare Foundation United States of America Canada France Germany Spain United Kingdom Switzerland

View original content:https://www.prnewswire.co.uk/news-releases/pierre-fabre-laboratories-and-the-esperare-foundation-to-be-honored-with-the-eurordis-company-award-for-patient-engagement-2024-in-their-approach-to-co-developing-a-treatment-for-xlhed-302060940.html